In patients with biochemical failure after prostatectomy, about two thirds showed detectable local disease at restaging. Multiparametric MRI alone detected local lesions in over one third of patients ...
Current PET/MRI imaging of healthy and damaged mouse kidneys using the dual contrast agent [18F][Gd(FL1)]. The imaging provides consistent signals from both PET and MRI. In healthy kidneys, the center ...
A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...
Hypoxia, or insufficient oxygen supply, plays a critical role in solid tumor growth and treatment resistance. The tumor microenvironment influences both the aggressiveness of a tumor and its ability ...
Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II ...
Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT improves locoregional staging compared with MRI in patients undergoing surgery for intermediate and high-risk prostate cancer. PSMA ...
Contemporary PET imaging has transitioned from a metabolic approach largely dominated by [¹⁸F]FDG to a multifaceted molecular platform encompassing a ...
Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results